2 does not limit negative emotions in nightmares to fear alone, as anger or sadness are also prevalent in nightmares. 3 In the research literature, nightmares that do not lead to awakening are usually referred to as bad dreams, 4 and nightmare induced distress 5 is differentiated from nightmare frequency (NF): two related but independent constructs.
Studies of the general population have indicated that nightmares are highly prevalent, with up to 70% having occasional nightmares 6 and approximately 2% to 5% of the adult population suffering from frequent nightmares. [6] [7] [8] [9] A similar percentage is estimated to "have a current problem with nightmares," as frequent and chronic nightmares are associated with disrupted sleep, 7 daily distress, 4, 8 and a variety of sleep complaints (e.g., night terrors, 9 chronic insomnia, 10 and sleep disordered breathing 11, 12 ) and affective complaints. 13, 14 Nightmares can have an idiopathic (unspecific) origin or occur as part of a posttraumatic stress disorder (PTSD) . 15 Approximately 50% to 70% of PTSD patients reports frequent nightmares. 16 This high prevalence and impact of nightmares has resulted in several treatment outcome studies. In general, older studies on pharmacological treatment of nightmares (e.g., antidepressants) have shown poor results, 17 while a recent systematic review on pharmacological treatment of posttraumatic nightmares showed that effects are inconclusive/tentative at best. 18 The only clear exception is the α1-antagonist prazosin, which has shown very promising outcomes for posttraumatic nightmare reduction in 3 relatively small randomized controlled trials (RCTs), 19, 20, 21 although it appears that prazosin must be used continuously as nightmares return after drug withdrawal. To date, cognitive-behavioral treatment (CBT) has gained more empirical support 22 and is the treatment-of-choice for nightmares, 14 particularly in long-term scenarios.
A range of cognitive-behavioral techniques seem to effectively decrease NF. Indirect CBT such as recording 23 one's nightmares and relaxation exercises 24 reduce NF. Nightmarefocused CBT such as exposure or systematic desensitisation 24 and techniques of cognitive restructuring 25 27 In a review, Wittmann et al. 22 concluded that IRT has been evaluated most extensively but has been tested only by one research group.
To date different nightmare treatment studies have not been reviewed systematically. The aim of this review is to evaluate whether CBT shows effects on diminishing nightmare frequency as promising as those seen in RCTs, and if so, which kind of CBT is most effective.
MetHOD Search Strategy
A systematic literature search was carried out in PsychInfo and PubMed for articles published on or before May 1, 2008. The terms "nightmares" AND "treatment" were used. References from each relevant paper, including 3 recent reviews of the literature 13.14.22 were examined for additional relevant studies.
The search strategy sought to obtain all relevant published databased RCTs based on the following criteria: nightmare treatment study, use of nonpharmacological treatment, not a qualitative case study, RCT. Follow-up studies were also included because they supplied information about the long-term effects of treatment. All RCTs on nightmare treatments for adults were reviewed by the first 2 authors.
Data Analysis
To adequately compare studies, Cohen's d was calculated for all studies with the software package G*power 3.0.5. 28 Because all studies were paired-sample studies, the between-group correlations have to be taken into account when deriving Cohen's d. However, most studies did not supply the correlations between groups or sufficient data to calculate Cohen's d for a pairedsample study. To adequately compare the Cohen's d between studies, a conservative correlation between pre-and post-test measurement of r = 0.5 was used for all studies. No effect sizes could be calculated for one study 29 because means and standard deviations were not reported, another study 30 only supplied NF information (Both authors were contacted, but could not supply the missing data). G*power 3.05 28 was used to further explore the nonsignificant differences within-and between-groups. When there was no within-group (pre-post) (p > 0.05) effect over time, we calculated the sample size necessary to detect a significant effect (using the difference in effect size, assumption of dependent groups and a power of 0.8). If there was no significant effect in a study between 2 groups (e.g., intervention, waiting list), the sample size necessary to achieve adequate power (0.8) was determined (independent groups assumed).
ReSUltS

Studies
The search string yielded 454 article titles in PsychInfo and 2645 in PubMed. After reviewing the abstracts, most articles were excluded because they were no-treatment articles. Of the remaining 108 articles, 70 were rejected because they were pharmacotherapy (30) or single case articles (40) . The remaining articles were then reviewed; 17 of these were excluded because they were not controlled studies, one 31 was excluded because it was in-group controlled, and one 32 was excluded because the population was not >18 years of age. Twelve articles remained-9 studies, 23 Table1) .
Study characteristics
Of the articles we examined, 10 were written in the US, one in the UK, 24 and one in the Netherlands 27 ( Table 2 ). The articles were published between 1978 and 2007. In the studies, a total of 437 participants were analyzed, the average number per study being 48.6 (SD = 35.8, range 20-114). In the 2 follow-up articles, intervention was offered to the waiting list (or recording condition) after 3 months. 35, 36 One preliminary 37 and original 26 study investigated sexual assault victims with PTSD and another study used students. 30 The remaining studies recruited participants through advertisements in the general media.
The published trials we examined varied in quality, yet none fulfilled CONSORT guidelines. 38 None of the articles explained how sample size was determined to achieve enough power. Only 3 articles 26,29,34 explained how randomization was achieved, and one covered the issue of blinding the procedure. 26 All articles described eligibility criteria of participants. For inclusion, most studies used a minimum NF of once a week. Miller Three studies did not suffer from any dropout. 23, 26, 27 Other studies mentioned the following reasons for dropout: failing 24 were more often single and had fewer nightmares in the relaxation group at baseline. Moreover, this study suffered the highest dropout (42% for treatment condition); this attrition rate is, however, not abnormal for self help treatment.
39
Four articles described an exposure type method, 24 34 and one study used LDT. 27 Most studies used a waiting-list control group, and one 30 was placebo controlled. Four studies used a second intervention next to the control group. These second interventions consisted of relaxation, 29 recording, 23, 30, 35 and LDT group intervention. 27 One study compared only 2 interventions without using a control group. 33 Treatment duration from a therapist ranged from 450 minutes 29 to zero minutes (self-help). 24 Most studies used one to 3 treatment sessions. All studies used a measurement for nightmare frequency; some studies used a diary to assess NF, 24 ,30,37 others used interviews, 29 the remaining studies used questionnaires. 23, [25] [26] [27] 33, 35, 36 Some studies also measured nightmare intensity (NI), 30, 33, 34 nightmare distress (ND) 26, 37 or amount of nights with nightmares per week. 25, 26, 30, 34, 36 Most studies used questionnaires to assess other sleep complaints or mental health complaints.
To test for changes in time within-and between-groups, repeated-measures analysis of variance and subsequent paired t-tests, was used by most articles. Some used only paired ttests, 23, 27 or did not describe their statistical analysis. 29, 30 One did not provide mean scores for variables, 29 and one only reported mean scores for NF. 30 Only 3 articles provided the intention-totreat analysis. 24, 26, 34 
intervention efficacy
Key results for all the studies are displayed using standardized effect sizes (Cohen's d) in Table 3 ; for a quick overview, see Table 4 . All articles used NF as a primary variable, and all found significant in-group differences (pre vs post) for intervention or placebo (range d = 0.7 to 2.9), and none for waiting list. Most studies found differences on secondary variables (range d = 0.4 to 1.6), one did not, 27 and 3 found these differences for only one of their interventions. 23, 24, 35 The insignificant findings that nightmare-focused CBT showed superior effects to other forms of nightmare treatment for both nightmare reduction and amelioration of associated sleep and affective complaints. So while indirect CBT such as recording and relaxation are effective in reducing nightmares (but not associated complaints), nightmare-focused CBT demonstrated better results on all outcomes, most notably the techniques of exposure and IRT. The only RCT comparing exposure with IRT found no statistical differences, 33 and this systematic review could not conclude that one was more effective than the other. The only possible difference so far may be a trend that IRT seemed to reduce related affective complaints to a larger degree. It would be interesting to compare IRT to exposure in a sample with adequate power.
Although IRT has been studied in more RCTs than exposure (5 vs 3), all studies on IRT have been conducted by the same research group. 22 According to APA criteria for empirically supported treatments 42 this would mean that IRT is a probably efficacious treatment instead of a well-established treatment (criterion V for well-established treatments: effects must have been demonstrated by at least 2 different investigators or investigatory teams). Criterion I, "superior to pill or psychological placebo or to another treatment," has not been fulfilled yet for IRT, as the only nightmare study so far with statistically significant differences between interventions was that of Burgess et al, 24 which showed stronger effects for exposure than for relaxation. Moreover, the effects of exposure have been demonstrated by might have been a result of a power issue as Spoormaker and van den Bout 27 would have needed an intervention group of n = 22 to pick up the difference in effect found for PTSD. The same applies to Neidhardt et al, 23 in which a sample size of 58 (SCL-90) 40 or 61 (SQ) 41 would have been needed per group to achieve adequate power to find this effect size. For the followup study, 35 17 participants were needed to significantly find the difference of d = 0.7. Burgess et al. 24 had enough power to determine effect sizes as small as d = 0.4.
Three IRT, 25,26,34 and 2 exposure 24,30 studies were able to find a significant group effect for the intervention compared to waiting list or placebo intervention. Burgess et al. 24 also found significant differences between 2 groups (exposure and relaxation). Other studies were not able to display significant group-effects. 23, 27, 33, 35 This may be a power issue, because the sample sizes of these studies were small. Sample sizes of n = 52, 33 n = 72, 23 and n = 24 27 were needed to detect significant (p < 0.05) differences in effect size with adequate power (0.8). Krakow et al. 37 does not mention a significant group-effect in the preliminary study, but the final report does report these groupeffects. 26 
DiScUSSiON
Although the number of included studies is relatively small and the studied groups are quite heterogeneous, this first systematic review on nightmare treatment was able to demonstrate 
